Skip to main content
Article
Adverse events in patients taking macrolide antibiotics versus placebo for any indication (Protocol)
Cochrane Database of Systematic Reviews
  • Malene Hansen, Bond University
  • Sarah Thorning, Bond University
  • Jeffrey K. Aronson, University of Oxford
  • Elaine Beller, Bond University
  • Paul Glasziou, Bond University
  • Tammy Hoffmann, Bond University
  • Chris Del Mar, Bond University
Date of this Version
1-1-2015
Document Type
Journal Article
Grant Number
CREMARA: NHMRC grant APP1044904
Publication Details

Citation only

Hansen, M. P, Thorning S, Aronson, J.K, Beller E.M,Glasziou P.P,Hoffmann, T.C, Del Mar C.B. (2015). Adverse events in patients taking macrolide antibiotics versus placebo for any indication. Cochrane Database of Systematic Reviews. 8, 1-10.

Access the journal

© Copyright, The Cochrane Collaboration, 2015

NHMRC Project Grant 1044904

2015 HERDC Submission


Abstract

Our primary objective is to quantify the incidence of any reported adverse event in patients taking macrolide antibiotics compared to placebo for any indication. The adverse events will be handled separately as adverse reactions, adverse effects, serious adverse events or subsequent carriage of resistant bacteria. Our secondary objective is to quantify the overall incidence of any reported adverse events in patients taking macrolide antibiotics compared to placebo.

Citation Information
Malene Hansen, Sarah Thorning, Jeffrey K. Aronson, Elaine Beller, et al.. "Adverse events in patients taking macrolide antibiotics versus placebo for any indication (Protocol)" Cochrane Database of Systematic Reviews Vol. 8 (2015) p. 1 - 10 ISSN: 1469-493X
Available at: http://works.bepress.com/tammy_hoffmann/94/